Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 281 Records) |
Query Trace: DPYD[original query] |
---|
Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine-induced toxicity in an Asian population. Cancer medicine 2022 12 . Kanai Masashi, Kawaguchi Takahisa, Kotaka Masahito, Manaka Dai, Hasegawa Junichi, Takagane Akinori, Munemoto Yoshinori, Kato Takeshi, Eto Tetsuya, Touyama Tetsuo, Matsui Takanori, Shinozaki Katsunori, Matsumoto Shigemi, Mizushima Tsunekazu, Mori Masaki, Sakamoto Junichi, Ohtsu Atsushi, Yoshino Takayuki, Saji Shigetoyo, Matsuda Fumihi |
Predicting Dihydropyrimidine Dehydrogenase Deficiency and Related 5-Fluorouracil Toxicity: Opportunities and Challenges of DPYD Exon Sequencing and the Role of Phenotyping Assays. International journal of molecular sciences 2022 11 23 (22): . De Luca Ottavia, Salerno Gerardo, De Bernardini Donatella, Torre Maria Simona, Simmaco Maurizio, Lionetto Luana, Gentile Giovanna, Borro Mari |
Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation. Pharmaceuticals (Basel, Switzerland) 2022 11 15 (11): . Stefanelli Berenice, Sellitto Carmine, De Bellis Emanuela, Torsiello Martina, Bertini Nicola, Pezzullo Angelo Maria, Corbi Graziamaria, Sabbatino Francesco, Pepe Stefano, Tesse Angela, Conti Valeria, Filippelli Amel |
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes. Scientific reports 2022 10 12 (1): 17928. Ohnami Sumiko, Naruoka Akane, Isaka Mitsuhiro, Mizuguchi Maki, Nakatani Sou, Kamada Fukumi, Shimoda Yuji, Sakai Ai, Ohshima Keiichi, Hatakeyama Keiichi, Maruyama Kouji, Ohde Yasuhisa, Kenmotsu Hirotsugu, Takahashi Toshiaki, Akiyama Yasuto, Nagashima Takeshi, Urakami Kenichi, Ohnami Shumpei, Yamaguchi K |
Dihydropyrimidine dehydrogenase (DPD) genotype and phenotype among Danish cancer patients: prevalence and correlation between DPYD-genotype variants and P-uracil concentrations. Acta oncologica (Stockholm, Sweden) 2022 10 61 (11): 1400-1405. Paulsen Niels Herluf, Qvortrup Camilla, Vojdeman Fie Juhl, Plomgaard Peter, Andersen Stig Ejdrup, Ramlov Anne, Bertelsen Birgitte, Rossing Maria, Nielsen Claus Gyrup, Hoffmann-Lücke Elke, Greibe Eva, Spangsberg Holm Hanne, Nielsen Heidi Hvid, Lolas Ihab Bishara Yousef, Madsen Jonna Skov, Bergmann Marianne Lerbaek, Mørk Morten, Fruekilde Palle B Nielsen, Bøttger Pernille, Petersen Peter Clausager, Nissen Peter Henrik, Feddersen Søren, Bergmann Troels K, Pfeiffer Per, Damkier P |
Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer. International journal of cancer 2022 Oct . Ma Yueyun, Li Wenjie, Chen Shiyu, Lin Shuimiao, Ding Sijie, Zhou Xiaomei, Liu Tongxin, Wang Rong, Wang W |
Genetic Variation in miR-27a Is Associated with Fluoropyrimidine-Associated Toxicity in Patients with Dihydropyrimidine Dehydrogenase Variants after Genotype-Guided Dose Reduction. International journal of molecular sciences 2023 9 24 (17): . Samantha Medwid, Theodore J Wigle, Cameron Ross, Richard B K |
Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. Frontiers in pharmacology 2023 9 14 1257745. Angela Wu, Helen Anderson, Curtis Hughesman, Sean Young, Caroline Lohrisch, Colin J D Ross, Bruce C Carlet |
Implementation of upfront DPYD genotyping with a low-cost and high-throughput assay to guide fluoropyrimidine treatment in cancer patients. Pharmacogenetics and genomics 2023 8 . Manuela Pinheiro, Ana Peixoto, Patrícia Rocha, Catarina Santos, Carla Escudeiro, Isabel Veiga, Miguel Porto, Joana Guerra, Ana Barbosa, Carla Pinto, Patrícia Arinto, Adriana Resende, Manuel R Teixei |
DPD deficiency in an Irish oncology centre: Prevalence and clinical implications. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2023 8 10781552231192107. Ruth Kieran, Taylor Mitchell, Afrah Al Fazari, Aleena Chinoy, Carolyn Moloney, John McCaffr |
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study. Cancers 2023 7 15 (13): . Matteo Conti, Elena Bolzacchini, Giovanna Luchena, Lorenza Bertu', Paola Tagliabue, Stefania Aglione, Antonio Ardizzoia, Jessica Arnoffi, Francesco Maria Guida, Alessandro Bertolini, Alessandro Pastorini, Maria Duro, Donato Bettega, Giovambattista Roda', Salvatore Artale, Alessandro Squizzato, Monica Giorda |
Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy. International journal of molecular sciences 2023 6 24 (12): . Javier Guijarro-Eguinoa, Sara Arjona-Hernandez, Stefan Stewart, Olga Pernia, Pedro Arias, Itsaso Losantos-García, Tania Rubio, Miranda Burdiel, Carlos Rodriguez-Antolin, Patricia Cruz-Castellanos, Oliver Higuera, Alberto M Borobia, Sonia Rodriguez-Novoa, Javier de Castro-Carpeño, Inmaculada Ibanez de Caceres, Rocio Rosas-Alon |
Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis. Value in health regional issues 2023 6 37 71-80. Soroush Ahmadi Fariman, Zahra Jahangard Rafsanjani, Mandana Hasanzad, Kimia Niksalehi, Shekoufeh Nikf |
Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breast cancer patients. Pharmacogenomics 2023 5 . Abdullah Alsulaiman, Hoyin Chu, Mohammed Al-Jumaan, Mohammed Alyahya, Yousef Al Marzooq, Fatmah Almulhim, Chittibabu Vatte, Areej Alnimer, Afnan Almuhanna, Amein Al-Ali, Saud H AlDubay |
Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study. The oncologist 2023 4 . Miarons Marta, Manzaneque Gordón Alba, Riera Pau, Gutiérrez Nicolás Fernando, |
Pharmacogenetics and Adverse Events in the Use of Fluoropyrimidine in a Cohort of Cancer Patients on Standard of Care Treatment in Zimbabwe. Journal of personalized medicine 2023 4 13 (4): . Boluwatife Lawrence Afolabi, Tinashe Mazhindu, Chikwambi Zedias, Margaret Borok, Ntokozo Ndlovu, Collen Masimirembwa, On Behalf Of Consortium For Genomics And Therapeutics In Africa Cg |
Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre. BMC cancer 2023 4 23 (1): 380. David K Lau, Caroline Fong, Faten Arouri, Lillian Cortez, Hannah Katifi, Reyes Gonzalez-Exposito, Muhammad Bilal Razzaq, Su Li, Aislinn Macklin-Doherty, Monica Arenas Hernandez, Michael Hubank, Charlotte Fribbens, David Watkins, Sheela Rao, Ian Chau, David Cunningham, Naureen Starli |
The role of gender pharmacogenetics in the personalization of drug treatment. The Journal of pharmacology and experimental therapeutics 2023 3 . Cecchin Erika, Posocco Bianca, Mezzalira Silvia, Appetecchia Marialuisa, Toffoli Giusep |
Discrepancies between Dihydropyrimidine dehydrogenase phenotyping and genotyping: what are the explanatory factors? British journal of clinical pharmacology 2023 3 . Arrivé C, Fonrose X, Thomas F, Roth G, Jacquet E, Brice A, Chirica C, Farneti D, Frenoux Coralie, Stanke-Labesque F, Gautier-Veyret |
Implementation and clinical benefit of DPYD genotyping in a Danish cancer population. ESMO open 2023 2 8 (1): 100782. Paulsen N H, Pfeiffer P, Ewertz M, Fruekilde P B N, Feddersen S, Holm H S, Bergmann T K, Qvortrup C, Damkier |
Risk of Toxicity from Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles. Clinical pharmacology and therapeutics 2023 12 . Javier Granados, Amy L Pasternak, N Lynn Henry, Vaibhav Sahai, Daniel L Her |
Thymidylate Synthase (TYMS) and Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphisms Associated With Severe Capecitabine Toxicity: The First Case From Saudi Arabia. Cureus 2023 12 15 (11): e49215. Nedal Bukhari, Hani Al-Mohanna, Fahad Almsn |
Updated DPYD HapB3 haplotype structure and implications for pharmacogenomic testing. Clinical and translational science 2023 12 . Amy J Turner, Cyrine E Haidar, Wenjian Yang, Erin C Boone, Steven M Offer, Philip E Empey, Andrew Haddad, Saba Tahir, Gunter Scharer, Ulrich Broeckel, Andrea Gaedi |
Developing DPYD Genotyping Method for Personalized Fluoropyrimidines Therapy. The journal of applied laboratory medicine 2023 12 . Betty Y L Wong, Zhenyu Li, Michael Jonathon Raphael, Carlo De Angelis, David M Hwang, Lei |
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece. Frontiers in pharmacology 2023 10 14 1248898. Georgia Ragia, Anthi Maslarinou, Natalia Atzemian, Eirini Biziota, Triantafyllia Koukaki, Charalampia Ioannou, Ioanna Balgkouranidou, George Kolios, Stylianos Kakolyris, Nikolaos Xenidis, Kyriakos Amarantidis, Vangelis G Manolopoul |
Capecitabine-induced hand-foot syndrome: A pharmacogenetic study beyond DPYD. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 1 159 114232. de With Mirjam, van Doorn Leni, Maasland Demi C, Mulder Tessa A M, Oomen-de Hoop Esther, Mostert Bianca, Homs Marjolein Y V, El Bouazzaoui Samira, Mathijssen Ron H J, van Schaik Ron H N, Bins Sand |
Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. Current oncology (Toronto, Ont.) 2024 1 31 (1): 274-295. Juan Pablo Cayún, Leslie Carol Cerpa, Alicia Colombo, Dante Daniel Cáceres, José Luis Leal, Felipe Reyes, Carolina Gutiérrez-Cáceres, Susan Calfunao, Nelson Miguel Varela, Luis Abel Quiñon |
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis. British journal of cancer 2024 1 . Gwénaël Le Teuff, Nathalie Cozic, Jean-Christophe Boyer, Valérie Boige, Robert B Diasio, Julien Taieb, Didier Meulendijks, Claire Palles, Matthias Schwab, Maarten Deenen, Carlo R Largiadèr, Anthony Marinaki, Barbara A Jennings, Yvonne Wettergren, Antonello Di Paolo, Eva Gross, Barna Budai, Stephen P Ackland, André B P van Kuilenburg, Howard L McLeod, Gérard Milano, Fabienne Thomas, Marie-Anne Loriot, David Kerr, Jan H M Schellens, Pierre Laurent-Puig, Qian Shi, Jean-Pierre Pignon, Marie-Christine Etienne-Grimaldi, |
Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity. The pharmacogenomics journal 2024 1 24 (1): 1. Romain Larrue, Sandy Fellah, Benjamin Hennart, Naoual Sabaouni, Nihad Boukrout, Cynthia Van der Hauwaert, Clément Delage, Meyling Cheok, Michaël Perrais, Christelle Cauffiez, Delphine Allorge, Nicolas Potti |
Common dihydropyrimidinase (DPYS) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort. Pharmacogenetics and genomics 2024 1 . Samantha J Medwid, Jaymie L Mailloux, Theodore J Wigle, Richard B K |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: